Cargando…
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Patients with TNBC are primarily treated with neoadjuvant chemotherapy (NAC). The response to NAC is prognostic, with reductions in overall survival and disease-free survival rates in those patients who do...
Autores principales: | Tang, Xiaojia, Thompson, Kevin J., Kalari, Krishna R., Sinnwell, Jason P., Suman, Vera J., Vedell, Peter T., McLaughlin, Sarah A., Northfelt, Donald W., Aspitia, Alvaro Moreno, Gray, Richard J., Carter, Jodi M., Weinshilboum, Richard, Wang, Liewei, Boughey, Judy C., Goetz, Matthew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207800/ https://www.ncbi.nlm.nih.gov/pubmed/37226243 http://dx.doi.org/10.1186/s13058-023-01656-x |
Ejemplares similares
-
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
por: Goetz, Matthew P., et al.
Publicado: (2017) -
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
por: Ellingson, Marissa S., et al.
Publicado: (2015) -
Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall
por: Moyer, Ann M., et al.
Publicado: (2019) -
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
por: Yu, Jia, et al.
Publicado: (2017) -
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
por: Yu, Jia, et al.
Publicado: (2021)